All News
Filter News
Found 809,065 articles
-
Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY Study with Pintuition®
1/24/2024
Sirius Medical is proud to celebrate the enrollment of the first patient in the MELODY Study using the innovative Sirius Pintuition System by Prof. Dr. Banys-Paluchowski.
-
Rob Albert appointed Chief Executive Officer of B. Braun of America Inc.
1/24/2024
The Board of Directors of B. Braun of America Inc. announced that they have appointed Rob Albert as Chief Executive Officer of B. Braun of America, succeeding Jean-Claude Dubacher who is taking on global management responsibilities, while remaining Chairman of the Board of B. Braun of America.
-
New Tool Reveals Gene Behavior in Bacteria
1/24/2024
Bacterial infections cause millions of deaths each year, with the global threat made worse by the increasing resistance of the microbes to antibiotic treatments.
-
SHL Medical partners with SteriPack Group to set up final assembly service
1/24/2024
SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership.
-
HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data
1/24/2024
HD Immune GmbH announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman.
-
Biosion Announces FDA Clearance of IND Application for BSI-082, a Novel Anti-SIRPα Monoclonal Antibody
1/24/2024
Biosion USA, Inc., a global clinical-stage R&D biotechnology company, announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for BSI-082, a novel anti-SIRPα monoclonal antibody candidate.
-
City of Hope, TGen Researchers Develop Machine-Learning Tool to Detect Cancer Earlier via Liquid Biopsy
1/24/2024
Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, and Translational Genomics Research Institute, a precision medicine research organization that is part of City of Hope, have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.
-
Sionna Therapeutics Announces Phase 1 Initiation for SION-109 in Cystic Fibrosis
1/24/2024
Sionna Therapeutics today announced that the first healthy subject has been dosed in a Phase 1 clinical trial of SION-109 following clearance of its Investigational New Drug application (IND) by the U.S. Food and Drug Administration (FDA).
-
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
1/24/2024
SciSparc Ltd. announced that it has entered into a standby equity purchase agreement with YA II PN, Ltd., a fund managed by Yorkville Advisors Global, LP.
-
Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors
1/24/2024
Sirnaomics Ltd., a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, announced the Company published a research article with NAR Cancer.
-
Research from the Korea University College of Medicine Explores the Combined Health Impact of Diabetes and Sarcopenia in the Elderly
1/24/2024
Diabetes mellitus and sarcopenia pose a substantial challenge to public health, especially among the elderly.
-
Applied Nanoscience Inc. Commissions U.S.-based Pilot Plant and Unveils Strategic IP Sale Process
1/24/2024
Applied Nanoscience Inc. disclosed that a newly constructed pilot plant has been commissioned to ensure reliable production scale-up of the company's groundbreaking NanoFense technology.
-
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
1/24/2024
ZWI Therapeutics, Inc. announces a Series A financing, the appointment of pharmaceutical industry veterans Drs. Larry Miller and Ron Cohen as Independent Directors to the company's Board of Directors.
-
Vitrolife AB (publ): Conference call full year report 2023
1/24/2024
Invitation to attend Vitrolife AB conference call regarding presentation of the fourth quarter and full year report 2023.
-
Twist Bioscience Expands Express Genes Rapid Synthesis Service
1/24/2024
Twist Bioscience Corporation today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days 1, to include larger DNA preparations up to 1 milligram.
-
Curing with Light! IlluminOss Celebrates 10,000 Light-Cured Implants Used By Surgeons To Strengthen Fragile Bone And Heal Geriatric Fractures
1/24/2024
IlluminOss Medical announces it has reached the important benchmark of having placed 10,000 of its patient conforming implants designed for the treatment of geriatric fractures.
-
Astrin Biosciences and Leading New York Cancer Center Announce New Cancer Research Collaboration
1/24/2024
In a significant advancement for cancer research and treatment, Astrin Biosciences, a leader in AI-empowered 3D holographic technology for cancer cell detection, has announced a comprehensive research collaboration with Memorial Sloan Kettering Cancer Center.
-
Unlocking Product Validation: Bioz and CE Elantech Set a New Standard for Success in Scientific Research
1/24/2024
Bioz, Inc., a leading Silicon Valley based AI software company committed to empowering scientists towards optimal scientific discovery, is delighted to announce its partnership with CE Elantech.
-
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne
1/24/2024
Ascletis Pharma Inc. announces dosing of the first patient in Phase III clinical trial of ASC40 for treatment of moderate to severe acne vulgaris at Huashan Hospital, Fudan University.
-
Alcami Opens New Advanced Pharma Storage and Services Facility in Central North Carolina
1/24/2024
Alcami Corporation announced the opening of its new 65,000 ft² state-of-the-art Pharma Storage and Services operations facility in Garner, North Carolina close to the Research Triangle Park biotech and pharma hub.